Global Meningococcal Conjugate Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Meningococcal Conjugate market report explains the definition, types, applications, major countries, and major players of the Meningococcal Conjugate market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Sanofi Pasteur

    • Baxter International

    • Glaxo Smith Kline

    • Pfizer

    • JN International Medical Corporation

    • Novartis

    • Biomed

    • Merck

    • Hualan Biological Engineering

    • Serum Institute of India

    By Type:

    • Menactra

    • Menveo

    • NeisVac-C

    • Nimenrix

    • Others

    By End-User:

    • Children

    • Preteens or Teens

    • Adults

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Meningococcal Conjugate Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Meningococcal Conjugate Outlook to 2028- Original Forecasts

    • 2.2 Meningococcal Conjugate Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Meningococcal Conjugate Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Meningococcal Conjugate Market- Recent Developments

    • 6.1 Meningococcal Conjugate Market News and Developments

    • 6.2 Meningococcal Conjugate Market Deals Landscape

    7 Meningococcal Conjugate Raw Materials and Cost Structure Analysis

    • 7.1 Meningococcal Conjugate Key Raw Materials

    • 7.2 Meningococcal Conjugate Price Trend of Key Raw Materials

    • 7.3 Meningococcal Conjugate Key Suppliers of Raw Materials

    • 7.4 Meningococcal Conjugate Market Concentration Rate of Raw Materials

    • 7.5 Meningococcal Conjugate Cost Structure Analysis

      • 7.5.1 Meningococcal Conjugate Raw Materials Analysis

      • 7.5.2 Meningococcal Conjugate Labor Cost Analysis

      • 7.5.3 Meningococcal Conjugate Manufacturing Expenses Analysis

    8 Global Meningococcal Conjugate Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Meningococcal Conjugate Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Meningococcal Conjugate Export by Region (Top 10 Countries) (2017-2028)

    9 Global Meningococcal Conjugate Market Outlook by Types and Applications to 2022

    • 9.1 Global Meningococcal Conjugate Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Menactra Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Menveo Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global NeisVac-C Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Nimenrix Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Meningococcal Conjugate Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Children Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Preteens or Teens Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Adults Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Meningococcal Conjugate Market Analysis and Outlook till 2022

    • 10.1 Global Meningococcal Conjugate Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Meningococcal Conjugate Consumption (2017-2022)

      • 10.2.2 Canada Meningococcal Conjugate Consumption (2017-2022)

      • 10.2.3 Mexico Meningococcal Conjugate Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Meningococcal Conjugate Consumption (2017-2022)

      • 10.3.2 UK Meningococcal Conjugate Consumption (2017-2022)

      • 10.3.3 Spain Meningococcal Conjugate Consumption (2017-2022)

      • 10.3.4 Belgium Meningococcal Conjugate Consumption (2017-2022)

      • 10.3.5 France Meningococcal Conjugate Consumption (2017-2022)

      • 10.3.6 Italy Meningococcal Conjugate Consumption (2017-2022)

      • 10.3.7 Denmark Meningococcal Conjugate Consumption (2017-2022)

      • 10.3.8 Finland Meningococcal Conjugate Consumption (2017-2022)

      • 10.3.9 Norway Meningococcal Conjugate Consumption (2017-2022)

      • 10.3.10 Sweden Meningococcal Conjugate Consumption (2017-2022)

      • 10.3.11 Poland Meningococcal Conjugate Consumption (2017-2022)

      • 10.3.12 Russia Meningococcal Conjugate Consumption (2017-2022)

      • 10.3.13 Turkey Meningococcal Conjugate Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Meningococcal Conjugate Consumption (2017-2022)

      • 10.4.2 Japan Meningococcal Conjugate Consumption (2017-2022)

      • 10.4.3 India Meningococcal Conjugate Consumption (2017-2022)

      • 10.4.4 South Korea Meningococcal Conjugate Consumption (2017-2022)

      • 10.4.5 Pakistan Meningococcal Conjugate Consumption (2017-2022)

      • 10.4.6 Bangladesh Meningococcal Conjugate Consumption (2017-2022)

      • 10.4.7 Indonesia Meningococcal Conjugate Consumption (2017-2022)

      • 10.4.8 Thailand Meningococcal Conjugate Consumption (2017-2022)

      • 10.4.9 Singapore Meningococcal Conjugate Consumption (2017-2022)

      • 10.4.10 Malaysia Meningococcal Conjugate Consumption (2017-2022)

      • 10.4.11 Philippines Meningococcal Conjugate Consumption (2017-2022)

      • 10.4.12 Vietnam Meningococcal Conjugate Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Meningococcal Conjugate Consumption (2017-2022)

      • 10.5.2 Colombia Meningococcal Conjugate Consumption (2017-2022)

      • 10.5.3 Chile Meningococcal Conjugate Consumption (2017-2022)

      • 10.5.4 Argentina Meningococcal Conjugate Consumption (2017-2022)

      • 10.5.5 Venezuela Meningococcal Conjugate Consumption (2017-2022)

      • 10.5.6 Peru Meningococcal Conjugate Consumption (2017-2022)

      • 10.5.7 Puerto Rico Meningococcal Conjugate Consumption (2017-2022)

      • 10.5.8 Ecuador Meningococcal Conjugate Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Meningococcal Conjugate Consumption (2017-2022)

      • 10.6.2 Kuwait Meningococcal Conjugate Consumption (2017-2022)

      • 10.6.3 Oman Meningococcal Conjugate Consumption (2017-2022)

      • 10.6.4 Qatar Meningococcal Conjugate Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Meningococcal Conjugate Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Meningococcal Conjugate Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Meningococcal Conjugate Consumption (2017-2022)

      • 10.7.2 South Africa Meningococcal Conjugate Consumption (2017-2022)

      • 10.7.3 Egypt Meningococcal Conjugate Consumption (2017-2022)

      • 10.7.4 Algeria Meningococcal Conjugate Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Meningococcal Conjugate Consumption (2017-2022)

      • 10.8.2 New Zealand Meningococcal Conjugate Consumption (2017-2022)

    11 Global Meningococcal Conjugate Competitive Analysis

    • 11.1 Sanofi Pasteur

      • 11.1.1 Sanofi Pasteur Company Details

      • 11.1.2 Sanofi Pasteur Meningococcal Conjugate Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Sanofi Pasteur Meningococcal Conjugate Main Business and Markets Served

      • 11.1.4 Sanofi Pasteur Meningococcal Conjugate Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Baxter International

      • 11.2.1 Baxter International Company Details

      • 11.2.2 Baxter International Meningococcal Conjugate Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Baxter International Meningococcal Conjugate Main Business and Markets Served

      • 11.2.4 Baxter International Meningococcal Conjugate Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Glaxo Smith Kline

      • 11.3.1 Glaxo Smith Kline Company Details

      • 11.3.2 Glaxo Smith Kline Meningococcal Conjugate Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Glaxo Smith Kline Meningococcal Conjugate Main Business and Markets Served

      • 11.3.4 Glaxo Smith Kline Meningococcal Conjugate Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Pfizer

      • 11.4.1 Pfizer Company Details

      • 11.4.2 Pfizer Meningococcal Conjugate Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Pfizer Meningococcal Conjugate Main Business and Markets Served

      • 11.4.4 Pfizer Meningococcal Conjugate Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 JN International Medical Corporation

      • 11.5.1 JN International Medical Corporation Company Details

      • 11.5.2 JN International Medical Corporation Meningococcal Conjugate Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 JN International Medical Corporation Meningococcal Conjugate Main Business and Markets Served

      • 11.5.4 JN International Medical Corporation Meningococcal Conjugate Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Novartis

      • 11.6.1 Novartis Company Details

      • 11.6.2 Novartis Meningococcal Conjugate Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Novartis Meningococcal Conjugate Main Business and Markets Served

      • 11.6.4 Novartis Meningococcal Conjugate Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Biomed

      • 11.7.1 Biomed Company Details

      • 11.7.2 Biomed Meningococcal Conjugate Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Biomed Meningococcal Conjugate Main Business and Markets Served

      • 11.7.4 Biomed Meningococcal Conjugate Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Merck

      • 11.8.1 Merck Company Details

      • 11.8.2 Merck Meningococcal Conjugate Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Merck Meningococcal Conjugate Main Business and Markets Served

      • 11.8.4 Merck Meningococcal Conjugate Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Hualan Biological Engineering

      • 11.9.1 Hualan Biological Engineering Company Details

      • 11.9.2 Hualan Biological Engineering Meningococcal Conjugate Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Hualan Biological Engineering Meningococcal Conjugate Main Business and Markets Served

      • 11.9.4 Hualan Biological Engineering Meningococcal Conjugate Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Serum Institute of India

      • 11.10.1 Serum Institute of India Company Details

      • 11.10.2 Serum Institute of India Meningococcal Conjugate Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Serum Institute of India Meningococcal Conjugate Main Business and Markets Served

      • 11.10.4 Serum Institute of India Meningococcal Conjugate Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    12 Global Meningococcal Conjugate Market Outlook by Types and Applications to 2028

    • 12.1 Global Meningococcal Conjugate Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Menactra Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Menveo Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global NeisVac-C Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global Nimenrix Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Meningococcal Conjugate Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Children Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Preteens or Teens Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Adults Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Meningococcal Conjugate Market Analysis and Outlook to 2028

    • 13.1 Global Meningococcal Conjugate Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Meningococcal Conjugate Consumption Forecast (2022-2028)

      • 13.2.2 Canada Meningococcal Conjugate Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Meningococcal Conjugate Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Meningococcal Conjugate Consumption Forecast (2022-2028)

      • 13.3.2 UK Meningococcal Conjugate Consumption Forecast (2022-2028)

      • 13.3.3 Spain Meningococcal Conjugate Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Meningococcal Conjugate Consumption Forecast (2022-2028)

      • 13.3.5 France Meningococcal Conjugate Consumption Forecast (2022-2028)

      • 13.3.6 Italy Meningococcal Conjugate Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Meningococcal Conjugate Consumption Forecast (2022-2028)

      • 13.3.8 Finland Meningococcal Conjugate Consumption Forecast (2022-2028)

      • 13.3.9 Norway Meningococcal Conjugate Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Meningococcal Conjugate Consumption Forecast (2022-2028)

      • 13.3.11 Poland Meningococcal Conjugate Consumption Forecast (2022-2028)

      • 13.3.12 Russia Meningococcal Conjugate Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Meningococcal Conjugate Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Meningococcal Conjugate Consumption Forecast (2022-2028)

      • 13.4.2 Japan Meningococcal Conjugate Consumption Forecast (2022-2028)

      • 13.4.3 India Meningococcal Conjugate Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Meningococcal Conjugate Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Meningococcal Conjugate Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Meningococcal Conjugate Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Meningococcal Conjugate Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Meningococcal Conjugate Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Meningococcal Conjugate Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Meningococcal Conjugate Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Meningococcal Conjugate Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Meningococcal Conjugate Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Meningococcal Conjugate Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Meningococcal Conjugate Consumption Forecast (2022-2028)

      • 13.5.3 Chile Meningococcal Conjugate Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Meningococcal Conjugate Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Meningococcal Conjugate Consumption Forecast (2022-2028)

      • 13.5.6 Peru Meningococcal Conjugate Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Meningococcal Conjugate Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Meningococcal Conjugate Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Meningococcal Conjugate Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Meningococcal Conjugate Consumption Forecast (2022-2028)

      • 13.6.3 Oman Meningococcal Conjugate Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Meningococcal Conjugate Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Meningococcal Conjugate Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Meningococcal Conjugate Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Meningococcal Conjugate Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Meningococcal Conjugate Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Meningococcal Conjugate Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Meningococcal Conjugate Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Meningococcal Conjugate Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Meningococcal Conjugate Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Meningococcal Conjugate

    • Figure of Meningococcal Conjugate Picture

    • Table Global Meningococcal Conjugate Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Meningococcal Conjugate Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Menactra Consumption and Growth Rate (2017-2022)

    • Figure Global Menveo Consumption and Growth Rate (2017-2022)

    • Figure Global NeisVac-C Consumption and Growth Rate (2017-2022)

    • Figure Global Nimenrix Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Children Consumption and Growth Rate (2017-2022)

    • Figure Global Preteens or Teens Consumption and Growth Rate (2017-2022)

    • Figure Global Adults Consumption and Growth Rate (2017-2022)

    • Figure Global Meningococcal Conjugate Consumption by Country (2017-2022)

    • Table North America Meningococcal Conjugate Consumption by Country (2017-2022)

    • Figure United States Meningococcal Conjugate Consumption and Growth Rate (2017-2022)

    • Figure Canada Meningococcal Conjugate Consumption and Growth Rate (2017-2022)

    • Figure Mexico Meningococcal Conjugate Consumption and Growth Rate (2017-2022)

    • Table Europe Meningococcal Conjugate Consumption by Country (2017-2022)

    • Figure Germany Meningococcal Conjugate Consumption and Growth Rate (2017-2022)

    • Figure UK Meningococcal Conjugate Consumption and Growth Rate (2017-2022)

    • Figure Spain Meningococcal Conjugate Consumption and Growth Rate (2017-2022)

    • Figure Belgium Meningococcal Conjugate Consumption and Growth Rate (2017-2022)

    • Figure France Meningococcal Conjugate Consumption and Growth Rate (2017-2022)

    • Figure Italy Meningococcal Conjugate Consumption and Growth Rate (2017-2022)

    • Figure Denmark Meningococcal Conjugate Consumption and Growth Rate (2017-2022)

    • Figure Finland Meningococcal Conjugate Consumption and Growth Rate (2017-2022)

    • Figure Norway Meningococcal Conjugate Consumption and Growth Rate (2017-2022)

    • Figure Sweden Meningococcal Conjugate Consumption and Growth Rate (2017-2022)

    • Figure Poland Meningococcal Conjugate Consumption and Growth Rate (2017-2022)

    • Figure Russia Meningococcal Conjugate Consumption and Growth Rate (2017-2022)

    • Figure Turkey Meningococcal Conjugate Consumption and Growth Rate (2017-2022)

    • Table APAC Meningococcal Conjugate Consumption by Country (2017-2022)

    • Figure China Meningococcal Conjugate Consumption and Growth Rate (2017-2022)

    • Figure Japan Meningococcal Conjugate Consumption and Growth Rate (2017-2022)

    • Figure India Meningococcal Conjugate Consumption and Growth Rate (2017-2022)

    • Figure South Korea Meningococcal Conjugate Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Meningococcal Conjugate Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Meningococcal Conjugate Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Meningococcal Conjugate Consumption and Growth Rate (2017-2022)

    • Figure Thailand Meningococcal Conjugate Consumption and Growth Rate (2017-2022)

    • Figure Singapore Meningococcal Conjugate Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Meningococcal Conjugate Consumption and Growth Rate (2017-2022)

    • Figure Philippines Meningococcal Conjugate Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Meningococcal Conjugate Consumption and Growth Rate (2017-2022)

    • Table South America Meningococcal Conjugate Consumption by Country (2017-2022)

    • Figure Brazil Meningococcal Conjugate Consumption and Growth Rate (2017-2022)

    • Figure Colombia Meningococcal Conjugate Consumption and Growth Rate (2017-2022)

    • Figure Chile Meningococcal Conjugate Consumption and Growth Rate (2017-2022)

    • Figure Argentina Meningococcal Conjugate Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Meningococcal Conjugate Consumption and Growth Rate (2017-2022)

    • Figure Peru Meningococcal Conjugate Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Meningococcal Conjugate Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Meningococcal Conjugate Consumption and Growth Rate (2017-2022)

    • Table GCC Meningococcal Conjugate Consumption by Country (2017-2022)

    • Figure Bahrain Meningococcal Conjugate Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Meningococcal Conjugate Consumption and Growth Rate (2017-2022)

    • Figure Oman Meningococcal Conjugate Consumption and Growth Rate (2017-2022)

    • Figure Qatar Meningococcal Conjugate Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Meningococcal Conjugate Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Meningococcal Conjugate Consumption and Growth Rate (2017-2022)

    • Table Africa Meningococcal Conjugate Consumption by Country (2017-2022)

    • Figure Nigeria Meningococcal Conjugate Consumption and Growth Rate (2017-2022)

    • Figure South Africa Meningococcal Conjugate Consumption and Growth Rate (2017-2022)

    • Figure Egypt Meningococcal Conjugate Consumption and Growth Rate (2017-2022)

    • Figure Algeria Meningococcal Conjugate Consumption and Growth Rate (2017-2022)

    • Table Oceania Meningococcal Conjugate Consumption by Country (2017-2022)

    • Figure Australia Meningococcal Conjugate Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Meningococcal Conjugate Consumption and Growth Rate (2017-2022)

    • Table Sanofi Pasteur Company Details

    • Table Sanofi Pasteur Meningococcal Conjugate Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Pasteur Meningococcal Conjugate Main Business and Markets Served

    • Table Sanofi Pasteur Meningococcal Conjugate Product Portfolio

    • Table Baxter International Company Details

    • Table Baxter International Meningococcal Conjugate Sales, Price, Value and Gross Profit (2017-2022)

    • Table Baxter International Meningococcal Conjugate Main Business and Markets Served

    • Table Baxter International Meningococcal Conjugate Product Portfolio

    • Table Glaxo Smith Kline Company Details

    • Table Glaxo Smith Kline Meningococcal Conjugate Sales, Price, Value and Gross Profit (2017-2022)

    • Table Glaxo Smith Kline Meningococcal Conjugate Main Business and Markets Served

    • Table Glaxo Smith Kline Meningococcal Conjugate Product Portfolio

    • Table Pfizer Company Details

    • Table Pfizer Meningococcal Conjugate Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Meningococcal Conjugate Main Business and Markets Served

    • Table Pfizer Meningococcal Conjugate Product Portfolio

    • Table JN International Medical Corporation Company Details

    • Table JN International Medical Corporation Meningococcal Conjugate Sales, Price, Value and Gross Profit (2017-2022)

    • Table JN International Medical Corporation Meningococcal Conjugate Main Business and Markets Served

    • Table JN International Medical Corporation Meningococcal Conjugate Product Portfolio

    • Table Novartis Company Details

    • Table Novartis Meningococcal Conjugate Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Meningococcal Conjugate Main Business and Markets Served

    • Table Novartis Meningococcal Conjugate Product Portfolio

    • Table Biomed Company Details

    • Table Biomed Meningococcal Conjugate Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biomed Meningococcal Conjugate Main Business and Markets Served

    • Table Biomed Meningococcal Conjugate Product Portfolio

    • Table Merck Company Details

    • Table Merck Meningococcal Conjugate Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Meningococcal Conjugate Main Business and Markets Served

    • Table Merck Meningococcal Conjugate Product Portfolio

    • Table Hualan Biological Engineering Company Details

    • Table Hualan Biological Engineering Meningococcal Conjugate Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hualan Biological Engineering Meningococcal Conjugate Main Business and Markets Served

    • Table Hualan Biological Engineering Meningococcal Conjugate Product Portfolio

    • Table Serum Institute of India Company Details

    • Table Serum Institute of India Meningococcal Conjugate Sales, Price, Value and Gross Profit (2017-2022)

    • Table Serum Institute of India Meningococcal Conjugate Main Business and Markets Served

    • Table Serum Institute of India Meningococcal Conjugate Product Portfolio

    • Figure Global Menactra Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Menveo Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global NeisVac-C Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Nimenrix Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Children Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Preteens or Teens Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Adults Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Meningococcal Conjugate Consumption Forecast by Country (2022-2028)

    • Table North America Meningococcal Conjugate Consumption Forecast by Country (2022-2028)

    • Figure United States Meningococcal Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Meningococcal Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Meningococcal Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Meningococcal Conjugate Consumption Forecast by Country (2022-2028)

    • Figure Germany Meningococcal Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Meningococcal Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Meningococcal Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Meningococcal Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Meningococcal Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Meningococcal Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Meningococcal Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Meningococcal Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Meningococcal Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Meningococcal Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Meningococcal Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Meningococcal Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Meningococcal Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Meningococcal Conjugate Consumption Forecast by Country (2022-2028)

    • Figure China Meningococcal Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Meningococcal Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Meningococcal Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Meningococcal Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Meningococcal Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Meningococcal Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Meningococcal Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Meningococcal Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Meningococcal Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Meningococcal Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Meningococcal Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Meningococcal Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Meningococcal Conjugate Consumption Forecast by Country (2022-2028)

    • Figure Brazil Meningococcal Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Meningococcal Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Meningococcal Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Meningococcal Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Meningococcal Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Meningococcal Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Meningococcal Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Meningococcal Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Meningococcal Conjugate Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Meningococcal Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Meningococcal Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Meningococcal Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Meningococcal Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Meningococcal Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Meningococcal Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Meningococcal Conjugate Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Meningococcal Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Meningococcal Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Meningococcal Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Meningococcal Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Meningococcal Conjugate Consumption Forecast by Country (2022-2028)

    • Figure Australia Meningococcal Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Meningococcal Conjugate Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.